Earnings · China A-shares
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276) earnings
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit +20.38% year on year, +11.70% excluding one-off items. Wave Radar's earnings-quality score is 95 of 100 (Sound). The stock moved +6.39% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- +20.38%
- Excl. one-offs YoY
- +11.70%
- Net profit QoQ
- +12.59%
- Result
- Good
- Quality score
- 95
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +6.17% | — |
| 3 days | +6.39% | — |
| 7 days | +10.19% | — |
| 14 days | +5.42% | — |
Report history
Over the last 8 reports, net profit grew year on year in 8 of them. The stock rose in the 3 trading days after 4 of 8 reports (average -0.12%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥6.92B | +20.38% | +11.70% | +5.26% | 1.05 | 12.17% | +6.39% | — | — |
| 2026 interim report | 2026-08-20 | ¥4.47B | +0.34% | -12.71% | -1.94% | 0.68 | 8.04% | -11.20% | -10.73% | -5.04% |
| 2026 Q1 report | 2026-04-23 | ¥2.28B | +21.78% | +16.59% | +12.98% | 0.34 | 4.15% | -0.11% | -17.14% | -15.58% |
| 2025 annual report | 2026-03-26 | ¥7.71B | +21.69% | +20.00% | +13.02% | 1.19 | 14.26% | +3.07% | +3.72% | -5.45% |
| 2025 Q3 report | 2025-10-28 | ¥5.75B | +24.50% | +21.08% | +14.85% | 0.89 | 11.09% | -6.16% | -6.79% | -3.41% |
| 2025 interim report | 2025-08-21 | ¥4.45B | +29.67% | +22.43% | +15.88% | 0.70 | 9.42% | +5.43% | +13.21% | +2.53% |
| 2025 Q1 report | 2025-04-25 | ¥1.87B | +36.90% | +29.35% | +20.14% | 0.30 | 4.08% | -2.99% | +7.00% | +3.76% |
| 2024 annual report | 2025-03-31 | ¥6.34B | +47.28% | +49.18% | +22.63% | 1.00 | 14.73% | +4.61% | +10.45% | +12.01% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
Stock valuations: 600276 · Stock news: 600276
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.